Destin Black

2.8k total citations
49 papers, 1.3k citations indexed

About

Destin Black is a scholar working on Oncology, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Destin Black has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Reproductive Medicine and 14 papers in Obstetrics and Gynecology. Recurrent topics in Destin Black's work include Ovarian cancer diagnosis and treatment (14 papers), Endometrial and Cervical Cancer Treatments (12 papers) and BRCA gene mutations in cancer (7 papers). Destin Black is often cited by papers focused on Ovarian cancer diagnosis and treatment (14 papers), Endometrial and Cervical Cancer Treatments (12 papers) and BRCA gene mutations in cancer (7 papers). Destin Black collaborates with scholars based in United States, Canada and Denmark. Destin Black's co-authors include Robert A. Soslow, Richard R. Barakat, Carmen Tornos, S. Dennis, Jeff Boyd, Jinru Shia, Amanda Hummer, Douglas A. Levine, William J. Fisk and Nadeem R. Abu‐Rustum and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of Virology.

In The Last Decade

Destin Black

48 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Destin Black United States	21	380	337	299	287	265	49	1.3k
Anna Fagotti Italy	25	456 1.2×	779 2.3×	59 0.2×	390 1.4×	450 1.7×	136	1.9k
Jakob Visfeldt Denmark	23	67 0.2×	298 0.9×	98 0.3×	515 1.8×	153 0.6×	88	1.6k
Rinat Bernstein‐Molho Israel	25	79 0.2×	160 0.5×	147 0.5×	594 2.1×	218 0.8×	116	1.9k
Enrico Vizza Italy	35	1.8k 4.7×	1.3k 3.9×	125 0.4×	393 1.4×	470 1.8×	163	3.3k
Naoto Furukawa Japan	19	386 1.0×	556 1.6×	54 0.2×	200 0.7×	119 0.4×	50	1.1k
Yolanda Benavente Spain	23	47 0.1×	36 0.1×	397 1.3×	243 0.8×	483 1.8×	57	1.6k
Inès Zidi Tunisia	16	106 0.3×	183 0.5×	30 0.1×	286 1.0×	207 0.8×	54	1.6k
William H. Bradley United States	17	365 1.0×	348 1.0×	24 0.1×	176 0.6×	269 1.0×	78	1.0k
Yoshimi Suzuki Japan	22	143 0.4×	37 0.1×	30 0.1×	425 1.5×	95 0.4×	57	1.4k
Alexandros Lambropoulos Greece	21	100 0.3×	46 0.1×	141 0.5×	378 1.3×	221 0.8×	55	1.0k

Countries citing papers authored by Destin Black

Since Specialization

Citations

This map shows the geographic impact of Destin Black's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Destin Black with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Destin Black more than expected).

Fields of papers citing papers by Destin Black

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Destin Black. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Destin Black. The network helps show where Destin Black may publish in the future.

Co-authorship network of co-authors of Destin Black

This figure shows the co-authorship network connecting the top 25 collaborators of Destin Black. A scholar is included among the top collaborators of Destin Black based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Destin Black. Destin Black is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hsiao, Susan J., Destin Black, Kelly A. Devereaux, et al.. (2025). Recommendations for Clinical Molecular Laboratories for Detection of Homologous Recombination Deficiency in Cancer. Journal of Molecular Diagnostics. 27(8). 685–704. 1 indexed citations

Leitão, Mario M., Kristin Bixel, Dana M. Chase, et al.. (2025). ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for early-stage cervical cancer. International Journal of Gynecological Cancer. 35(7). 101760–101760. 2 indexed citations

Jørgensen, Trine Lembrecht, Destin Black, David Cibula, et al.. (2024). Time course of adverse events in primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy in the ENGOT-EN-6-NSGO/GOG-3031/RUBY trial.. Journal of Clinical Oncology. 42(16_suppl). 5607–5607. 1 indexed citations

Mirza, Mansoor Raza, Destin Black, Antonella Savarese, et al.. (2024). 38MO Progression-free survival (PFS) in primary advanced or recurrent endometrial cancer (pA/rEC) in the overall and mismatch repair proficient (MMR/MSS) populations and in histological and molecular subgroups: Results from part 2 of the RUBY trial. ESMO Open. 9. 103538–103538. 6 indexed citations

Ghamande, Sharad, Lars Hanker, Destin Black, et al.. (2024). Dostarlimab plus chemotherapy followed by dostarlimab plus niraparib maintenance therapy among patients with primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial. Gynecologic Oncology. 190. S6–S6. 11 indexed citations

Powell, Matthew A., Annika Auranen, Lyndsay Willmott, et al.. (2024). Overall survival among patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy in the ENGOT-EN6-NSGO/GOG-3031/RUBY Trial. Gynecologic Oncology. 190. S4–S5. 5 indexed citations

Slomovitz, Brian M., Robert L. Coleman, Lucy Gilbert, et al.. (2023). 750P PFS2 and adjustment of overall survival (OS) for subsequent anticancer therapy in patients (pts) with primary advanced or recurrent endometrial cancer (pA/rEC) treated with dostarlimab plus chemotherapy or chemotherapy alone in the ENGOT-EN3-NSGO/GOG-3031/RUBY trial. Annals of Oncology. 34. S514–S515. 2 indexed citations

Mirza, Mansoor Raza, Dana M. Chase, Brian M. Slomovitz, et al.. (2023). Dostarlimab in combination with chemotherapy for the treatment of primary advanced or recurrent endometrial cancer: a placebo-controlled randomized phase 3 trial (ENGOT-EN6-NSGO/GOG-3031/RUBY) (LBA 11). Gynecologic Oncology. 176. S43–S44. 2 indexed citations

Auranen, Annika, Destin Black, Vladyslav Sukhin, et al.. (2023). #540 Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY). A11.2–A12. 2 indexed citations

10.

Wang, Yuping, et al.. (2022). Laparoscopic guided liposomal bupivacaine injection compared to transversus abdominus plane block for postoperative pain after robotic gynecologic oncology surgery. Gynecologic Oncology. 166(3). 432–437. 6 indexed citations

11.

Cowan, Renee A., Destin Black, Lien Hoang, et al.. (2016). A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease. Gynecologic Oncology. 142(1). 139–143. 49 indexed citations

12.

Conrad, Lesley B., Lynn J. Groome, & Destin Black. (2015). Management of Persistent Postpartum Hemorrhage Caused by Inner Myometrial Lacerations. Obstetrics and Gynecology. 126(2). 266–269. 8 indexed citations

13.

Black, Destin, Douglas A. Levine, Joanne F. Chou, et al.. (2008). Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer. Gynecologic Oncology. 109(1). 39–42. 18 indexed citations

14.

Black, Destin, et al.. (2007). Difficulties in Assessing the Depth of Myometrial Invasion in Endometrial Carcinoma. International Journal of Gynecological Pathology. 26(2). 115–123. 58 indexed citations

15.

Soslow, Robert A., et al.. (2007). Utility of Immunohistochemistry in Predicting Microsatellite Instability in Endometrial Carcinoma. The American Journal of Surgical Pathology. 31(5). 744–751. 94 indexed citations

16.

Abu‐Rustum, Nadeem R., Yukio Sonoda, Destin Black, S. Dennis, & Richard R. Barakat. (2006). Cystoscopic temporary ureteral catheterization during radical vaginal and abdominal trachelectomy. Gynecologic Oncology. 103(2). 729–731. 25 indexed citations

17.

Abu‐Rustum, Nadeem R., Yukio Sonoda, Destin Black, et al.. (2006). Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: Technique and review of the literature. Gynecologic Oncology. 103(3). 807–813. 110 indexed citations

18.

Sorrells, Donald L., Ghali E. Ghali, Carol Meschonat, et al.. (1999). Competitive PCR to detect eIF4E gene amplification in head and neck cancer. Head & Neck. 21(1). 60–65. 28 indexed citations

19.

Sorrells, Donald L., Destin Black, Carol Meschonat, et al.. (1998). Detection of eIF4E gene amplification in breast cancer by competitive PCR. Annals of Surgical Oncology. 5(3). 232–237. 43 indexed citations

20.

Black, Destin. (1983). Need, demand, supply.. PubMed. 1(1). 3–5.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact